Literature DB >> 18071765

Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease.

S Ramia1, A I Sharara, M El-Zaatari, F Ramlawi, Z Mahfoud.   

Abstract

Occult hepatitis B virus (HBV) infection, characterised by the presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg), was investigated in 98 Lebanese patients with chronic hepatitis C liver disease and 85 control subjects recruited from eight institutions in different parts of the country. The prevalence of occult HBV infection ranged from 11.9% to 44.4% in hepatitis C virus (HCV)-infected patients and it increased with increasing severity of the liver disease. The overall rate of HBV DNA in our 98 HCV-infected patients was 16.3%. On the other hand, the rate of HBV DNA was 41.0% in anti-HBc alone positive patients compared to only 7.1% in healthy controls who were also anti-HBc alone positive (p < 0.001). Moreover, the prevalence HBV DNA increased with increasing severity of the liver disease, but this increase was only marginally significant and, perhaps, could have been significant if more patients were involved in the study. Although Lebanon is an area of low endemicity for both HBV and HCV, occult HBV infection is common in HCV-infected patients. The presence of HBV DNA, therefore, presents a challenge for the effective laboratory diagnosis of hepatitis B, particularly if polymerase chain reaction (PCR)-based HBV detection methods are not used.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18071765     DOI: 10.1007/s10096-007-0429-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  Prevalence of restriction fragment length polymorphism patterns of hepatitis B virus compatible with genotype D in Lebanon.

Authors:  A I Sharara; S Ramia; F Ramlawi; B Farhat; M Bahlawan; U Farhat; M Alameddine; E Nour; R Sayegh; C Yaghi; H Assi; A Ferzli; R Shatila
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10-08       Impact factor: 3.267

2.  Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus-infected chronic hepatitis patients.

Authors:  K Koike; M Kobayashi; M Gondo; I Hayashi; T Osuga; S Takada
Journal:  J Med Virol       Date:  1998-04       Impact factor: 2.327

3.  Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method.

Authors:  M Lindh; A S Andersson; A Gusdal
Journal:  J Infect Dis       Date:  1997-06       Impact factor: 5.226

4.  Hepatitis C virus is frequently coinfected with serum marker-negative hepatitis B virus: probable replication promotion of the former by the latter as demonstrated by in vitro cotransfection.

Authors:  T Uchida; Y Kaneita; K Gotoh; H Kanagawa; H Kouyama; T Kawanishi; S Mima
Journal:  J Med Virol       Date:  1997-08       Impact factor: 2.327

5.  Prevalence of hepatitis B virus DNA in anti-HBc-positive/HBsAg-negative sera correlates with HCV but not HIV serostatus.

Authors:  Christian Drosten; Thomas Nippraschk; Christoph Manegold; Helga Meisel; Veronika Brixner; W Kurt Roth; Anani Apedjinou; Stephan Günther
Journal:  J Clin Virol       Date:  2004-01       Impact factor: 3.168

6.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response.

Authors:  B Rehermann; C Ferrari; C Pasquinelli; F V Chisari
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

7.  Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.

Authors:  T I Huo; J C Wu; P C Lee; G Y Chau; W Y Lui; S H Tsay; L T Ting; F Y Chang; S D Lee
Journal:  Hepatology       Date:  1998-07       Impact factor: 17.425

Review 8.  The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.

Authors:  A Alberti; P Pontisso; L Chemello; G Fattovich; L Benvegnù; F Belussi; M S De Mitri
Journal:  J Hepatol       Date:  1995       Impact factor: 25.083

9.  Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection.

Authors:  Teresa Pollicino; Giovanni Squadrito; Giovanni Cerenzia; Irene Cacciola; Giuseppina Raffa; Antonio Craxi; Fabio Farinati; Gabriele Missale; Antonina Smedile; Claudio Tiribelli; Erica Villa; Giovanni Raimondo
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

10.  Hepatitis B virus DNA in serum of 'anti-HBc only'-positive healthy Lebanese blood donors: significance and possible implications.

Authors:  M El-Zaatari; H Kazma; M Naboulsi-Majzoub; M Haidar; F Ramlawi; Z Mahfoud; S Ramia
Journal:  J Hosp Infect       Date:  2007-05-30       Impact factor: 3.926

View more
  3 in total

Review 1.  Role of occult hepatitis B virus infection in chronic hepatitis C.

Authors:  Nicola Coppola; Lorenzo Onorato; Mariantonietta Pisaturo; Margherita Macera; Caterina Sagnelli; Salvatore Martini; Evangelista Sagnelli
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

Review 2.  Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.

Authors:  Peiman Habibollahi; Saeid Safari; Nasser E Daryani; Seyed M Alavian
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

3.  Prevalence of occult hepatitis B virus infection in a cohort of HIV-positive patients resident in Sicily, Italy.

Authors:  Fabio Tramuto; Carmelo Massimo Maida; Giuseppina M E Colomba; Paola Di Carlo; Francesco Vitale
Journal:  Biomed Res Int       Date:  2013-08-26       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.